{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:37:09Z","timestamp":1792683429870,"version":"4.5.0"},"reference-count":67,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Psychiatry"],"published-print":{"date-parts":[[2023,4,1]]},"abstract":"\n Importance<\/jats:title>\n \n The cerebral serotonin 4 (5-HT\n 4<\/jats:sub>\n ) receptor is a promising novel target for treatment of major depressive disorder (MDD), and pharmacological stimulation of the 5-HT\n 4<\/jats:sub>\n receptor has been associated with improved learning and memory in healthy individuals.\n <\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n \n To map the neurobiological signatures of patients with untreated MDD compared with healthy controls and to examine the association between cerebral 5-HT\n 4<\/jats:sub>\n receptor binding and cognitive functions in the depressed state.\n <\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n \n This case-control study used baseline data from the NeuroPharm clinical depression trial in Denmark. Adult participants included antidepressant-free outpatients with a current moderate to severe depressive episode and healthy controls. All participants completed positron emission tomography (PET) scanning with [\n 11<\/jats:sup>\n C]SB207145 for quantification of brain 5-HT\n 4<\/jats:sub>\n receptor binding, but only the patients underwent cognitive testing. Data analyses were performed from January 21, 2020, to April 22, 2022.\n <\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n \n The main study outcome was the group difference in cerebral 5-HT\n 4<\/jats:sub>\n receptor binding between patients with MDD and healthy controls. In addition, the association between 5-HT\n 4<\/jats:sub>\n receptor binding and verbal memory performance in the patient group was tested. Other cognitive domains (working memory, reaction time, emotion recognition bias, and negative social emotions) were assessed as secondary outcomes.\n <\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n A total of 90 patients with untreated MDD (mean [SD] age, 27.1 [8.2] years; 64 women [71.1%]) and 91 healthy controls (mean [SD] age, 27.1 [8.0] years; 55 women [60.4%]) were included in the analysis. Patients with current MDD had significantly lower cerebral 5-HT\n 4<\/jats:sub>\n receptor binding than healthy controls (\u22127.0%; 95% CI, \u221211.2 to \u22122.7;\n P<\/jats:italic>\n \u2009=\u2009.002). In patients with MDD, there was a correlation between cerebral 5-HT\n 4<\/jats:sub>\n receptor binding and verbal memory (\n r<\/jats:italic>\n \u2009=\u20090.29;\n P<\/jats:italic>\n \u2009=\u2009.02).\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n \n Results of this study show that cerebral 5-HT\n 4<\/jats:sub>\n receptor binding was lower in patients with MDD than in healthy controls and that the memory dysfunction in patients with MDD was associated with lower cerebral 5-HT\n 4<\/jats:sub>\n receptor binding. The cerebral 5-HT\n 4<\/jats:sub>\n receptor is a promising treatment target for memory dysfunction in patients with MDD.\n <\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamapsychiatry.2022.4539","type":"journal-article","created":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T11:00:46Z","timestamp":1675854046000},"page":"296","source":"Crossref","is-referenced-by-count":48,"title":["Serotonin 4 Receptor Brain Binding in Major Depressive Disorder and Association With Memory Dysfunction"],"prefix":"10.1001","volume":"80","author":[{"given":"Kristin","family":"K\u00f6hler-Forsberg","sequence":"first","affiliation":[{"name":"Neurobiology Research Unit, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark"},{"name":"Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark"},{"name":"Psychiatric Center Copenhagen, Rigshospitalet, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vibeke H.","family":"Dam","sequence":"additional","affiliation":[{"name":"Neurobiology Research Unit, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark"},{"name":"Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brice","family":"Ozenne","sequence":"additional","affiliation":[{"name":"Neurobiology Research Unit, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark"},{"name":"Department of Public Health, Section of Biostatistics, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjali","family":"Sankar","sequence":"additional","affiliation":[{"name":"Neurobiology Research Unit, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Beliveau","sequence":"additional","affiliation":[{"name":"Neurobiology Research Unit, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark"},{"name":"Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth B.","family":"Landman","sequence":"additional","affiliation":[{"name":"Neurobiology Research Unit, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f8ren V.","family":"Larsen","sequence":"additional","affiliation":[{"name":"Neurobiology Research Unit, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark"},{"name":"Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asbj\u00f8rn S.","family":"Poulsen","sequence":"additional","affiliation":[{"name":"Neurobiology Research Unit, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Teng","family":"Ip","sequence":"additional","affiliation":[{"name":"Neurobiology Research Unit, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark"},{"name":"Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark"},{"name":"Department of Clinical Pharmacology, H. Lundbeck A\/S, Valby, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"J\u00f8rgensen","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark"},{"name":"Psychiatric Center Copenhagen, Rigshospitalet, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Meyer","sequence":"additional","affiliation":[{"name":"Center for Referral and Diagnostics, Mental Health Services, Capital Region of Denmark, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dea S.","family":"Stenb\u00e6k","sequence":"additional","affiliation":[{"name":"Neurobiology Research Unit, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark"},{"name":"Department of Psychology, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans R. L.","family":"Eiberg","sequence":"additional","affiliation":[{"name":"Department of Cellular and Molecular Medicine, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Madsen","sequence":"additional","affiliation":[{"name":"Department of Clinical Physiology and Nuclear Medicine, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus","family":"Svarer","sequence":"additional","affiliation":[{"name":"Neurobiology Research Unit, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin B.","family":"J\u00f8rgensen","sequence":"additional","affiliation":[{"name":"Neurobiology Research Unit, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark"},{"name":"Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark"},{"name":"Psychiatric Center Copenhagen, Rigshospitalet, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vibe G.","family":"Frokjaer","sequence":"additional","affiliation":[{"name":"Neurobiology Research Unit, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark"},{"name":"Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark"},{"name":"Psychiatric Center Copenhagen, Rigshospitalet, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gitte M.","family":"Knudsen","sequence":"additional","affiliation":[{"name":"Neurobiology Research Unit, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark"},{"name":"Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"1","key":"yoi220090r1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0301-0082(98)00097-5","article-title":"Serotonin and the sleep\/wake cycle: special emphasis on microdialysis studies.","volume":"60","author":"Portas","year":"2000","journal-title":"Prog Neurobiol"},{"issue":"1","key":"yoi220090r2","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1515\/tnsci-2016-0007","article-title":"The serotonergic system and cognitive function.","volume":"7","author":"\u0160vob \u0160trac","year":"2016","journal-title":"Transl Neurosci"},{"issue":"1","key":"yoi220090r3","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3390\/nu8010056","article-title":"Influence of tryptophan and serotonin on mood and cognition with a possible role of the gut-brain axis.","volume":"8","author":"Jenkins","year":"2016","journal-title":"Nutrients"},{"issue":"2","key":"yoi220090r4","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1002\/wps.v14.2","article-title":"What has serotonin to do with depression?","volume":"14","author":"Cowen","year":"2015","journal-title":"World Psychiatry"},{"issue":"11","key":"yoi220090r5","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/S2215-0366(20)30036-5","article-title":"Treatment outcomes for depression: challenges and opportunities.","volume":"7","author":"Cuijpers","year":"2020","journal-title":"Lancet Psychiatry"},{"issue":"1","key":"yoi220090r6","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1037\/neu0000319","article-title":"Cognitive functioning in the first-episode of major depressive disorder: a systematic review and meta-analysis.","volume":"31","author":"Ahern","year":"2017","journal-title":"Neuropsychology"},{"issue":"1","key":"yoi220090r7","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s11065-018-9369-5","article-title":"A meta-analysis of the effects of antidepressants on cognitive functioning in depressed and non-depressed samples.","volume":"28","author":"Prado","year":"2018","journal-title":"Neuropsychol Rev"},{"issue":"10","key":"yoi220090r8","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S2215-0366(19)30291-3","article-title":"Cognitive function following a major depressive episode: a systematic review and meta-analysis.","volume":"6","author":"Semkovska","year":"2019","journal-title":"Lancet Psychiatry"},{"issue":"12","key":"yoi220090r9","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1016\/j.euroneuro.2016.09.641","article-title":"Systematic review of randomized controlled trials of candidate treatments for cognitive impairment in depression and methodological challenges in the field.","volume":"26","author":"Miskowiak","year":"2016","journal-title":"Eur Neuropsychopharmacol"},{"issue":"1","key":"yoi220090r10","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1177\/1073858414561303","article-title":"Serotonin 1A and serotonin 4 receptors: essential mediators of the neurogenic and behavioral actions of antidepressants.","volume":"22","author":"Samuels","year":"2016","journal-title":"Neuroscientist"},{"issue":"7","key":"yoi220090r11","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1017\/S0033291720000604","article-title":"Translating the promise of 5HT4 receptor agonists for the treatment of depression.","volume":"51","author":"Murphy","year":"2021","journal-title":"Psychol Med"},{"issue":"1","key":"yoi220090r12","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1523\/JNEUROSCI.2830-16.2016","article-title":"A high-resolution in vivo atlas of the human brain\u2019s serotonin system.","volume":"37","author":"Beliveau","year":"2017","journal-title":"J Neurosci"},{"issue":"11","key":"yoi220090r13","doi-asserted-by":"publisher","first-page":"3581","DOI":"10.3390\/ijms19113581","article-title":"Alterations of expression of the serotonin 5-HT4 receptor in brain disorders.","volume":"19","author":"Rebholz","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"5","key":"yoi220090r14","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.neuron.2007.07.041","article-title":"Serotonin(4) (5-HT(4)) receptor agonists are putative antidepressants with a rapid onset of action.","volume":"55","author":"Lucas","year":"2007","journal-title":"Neuron"},{"issue":"6","key":"yoi220090r15","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1038\/npp.2013.332","article-title":"Rapid anxiolytic effects of a 5-HT4 receptor agonist are mediated by a neurogenesis-independent mechanism.","volume":"39","author":"Mendez-David","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"yoi220090r16","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.neulet.2016.01.055","article-title":"Chronic 5-HT4 receptor agonist treatment restores learning and memory deficits in a neuroendocrine mouse model of anxiety\/depression.","volume":"616","author":"Darcet","year":"2016","journal-title":"Neurosci Lett"},{"issue":"5","key":"yoi220090r17","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1017\/S1461145711000782","article-title":"Modulation of neuroplasticity pathways and antidepressant-like behavioural responses following the short-term (3 and 7 days) administration of the 5-HT4 receptor agonist RS67333.","volume":"15","author":"Pascual-Brazo","year":"2012","journal-title":"Int J Neuropsychopharmacol"},{"issue":"3","key":"yoi220090r18","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/s41386-019-0540-3","article-title":"Prophylactic efficacy of 5-HT4R agonists against stress.","volume":"45","author":"Chen","year":"2020","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"yoi220090r19","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyu034","article-title":"Familial risk for major depression is associated with lower striatal 5-HT(4) receptor binding.","volume":"18","author":"Madsen","year":"2015","journal-title":"Int J Neuropsychopharmacol"},{"issue":"9","key":"yoi220090r20","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.tips.2008.07.001","article-title":"A role for the 5-HT(1A), 5-HT4 and 5-HT6 receptors in learning and memory.","volume":"29","author":"King","year":"2008","journal-title":"Trends Pharmacol Sci"},{"key":"yoi220090r21","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.bbr.2015.07.020","article-title":"Chronic activation of 5-HT4 receptors or blockade of 5-HT6 receptors improve memory performances.","volume":"293","author":"Quiedeville","year":"2015","journal-title":"Behav Brain Res"},{"key":"yoi220090r22","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.nlm.2016.06.014","article-title":"The serotonergic 5-HT4 receptor: a unique modulator of hippocampal synaptic information processing and cognition.","volume":"138","author":"Hagena","year":"2017","journal-title":"Neurobiol Learn Mem"},{"issue":"11","key":"yoi220090r23","doi-asserted-by":"publisher","first-page":"3066","DOI":"10.1002\/hbm.22123","article-title":"The 5-HT4 receptor levels in hippocampus correlates inversely with memory test performance in humans.","volume":"34","author":"Haahr","year":"2013","journal-title":"Hum Brain Mapp"},{"issue":"4","key":"yoi220090r24","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.2017.7.issue-4","article-title":"Brain serotonin 4 receptor binding is inversely associated with verbal memory recall.","volume":"7","author":"Stenb\u00e6k","year":"2017","journal-title":"Brain Behav"},{"key":"yoi220090r25","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.1017\/S0033291719002836","article-title":"A role for 5-HT4 receptors in human learning and memory.","volume":"50","author":"Murphy","year":"2020","journal-title":"Psychol Med"},{"issue":"1","key":"yoi220090r26","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/s41398-021-01568-4","article-title":"D\u00e9j\u00e0-vu? neural and behavioural effects of the 5-HT4 receptor agonist, prucalopride, in a hippocampal-dependent memory task.","volume":"11","author":"de Cates","year":"2021","journal-title":"Transl Psychiatry"},{"issue":"641","key":"yoi220090r27","doi-asserted-by":"publisher","first-page":"641","DOI":"10.3389\/fpsyt.2020.00641","article-title":"Predicting treatment outcome in major depressive disorder using serotonin 4 receptor PET brain imaging, functional MRI, cognitive-, EEG-based, and peripheral biomarkers: a neuroPharm open label clinical trial protocol.","volume":"11","author":"K\u00f6hler-Forsberg","year":"2020","journal-title":"Front Psychiatry"},{"issue":"4","key":"yoi220090r28","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1111\/bjc.1967.6.issue-4","article-title":"Development of a rating scale for primary depressive illness.","volume":"6","author":"Hamilton","year":"1967","journal-title":"Br J Soc Clin Psychol"},{"key":"yoi220090r29","first-page":"22","article-title":"The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10.","volume":"59","author":"Sheehan","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"yoi220090r30","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/j.neuroimage.2015.04.025","article-title":"The Center for Integrated Molecular Brain Imaging (Cimbi) database.","volume":"124","author":"Knudsen","year":"2016","journal-title":"Neuroimage"},{"key":"yoi220090r31","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.euroneuro.2020.12.010","article-title":"Reward processing in major depressive disorder and prediction of treatment response - Neuropharm study.","volume":"44","author":"Brandt","year":"2021","journal-title":"Eur Neuropsychopharmacol"},{"issue":"5","key":"yoi220090r32","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1177\/02698811221089035","article-title":"Emotional faces processing in major depressive disorder and prediction of antidepressant treatment response: a NeuroPharm study.","volume":"36","author":"Fisher","year":"2022","journal-title":"J Psychopharmacol"},{"key":"yoi220090r33","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jpsychires.2021.06.021","article-title":"NeuroPharm study: EEG wakefulness regulation as a biomarker in MDD.","volume":"141","author":"Ip","year":"2021","journal-title":"J Psychiatr Res"},{"key":"yoi220090r34","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.euroneuro.2021.03.024","article-title":"Pretreatment qEEG biomarkers for predicting pharmacological treatment outcome in major depressive disorder: independent validation from the NeuroPharm study.","volume":"49","author":"Ip","year":"2021","journal-title":"Eur Neuropsychopharmacol"},{"key":"yoi220090r35","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1017\/S0033291720000938","article-title":"Hot and cold cognitive disturbances in antidepressant-free patients with major depressive disorder: a NeuroPharm study.","volume":"51","author":"Dam","year":"2021","journal-title":"Psychol Med"},{"issue":"961","key":"yoi220090r36","doi-asserted-by":"publisher","first-page":"961","DOI":"10.3389\/fpsyg.2020.00961","article-title":"Psychometric properties of the Verbal Affective Memory Test-26 and evaluation of affective biases in major depressive disorder.","volume":"11","author":"Hjordt","year":"2020","journal-title":"Front Psychol"},{"issue":"1","key":"yoi220090r37","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s41398-022-01969-z","article-title":"Systemic DNA and RNA damage from oxidation after serotonergic treatment of unipolar depression.","volume":"12","author":"Jorgensen","year":"2022","journal-title":"Transl Psychiatry"},{"issue":"1","key":"yoi220090r38","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s41398-022-02034-5","article-title":"Concurrent anxiety in patients with major depression and cerebral serotonin 4 receptor binding: a NeuroPharm-1 study.","volume":"12","author":"K\u00f6hler-Forsberg","year":"2022","journal-title":"Transl Psychiatry"},{"issue":"6","key":"yoi220090r39","doi-asserted-by":"publisher","first-page":"900","DOI":"10.2967\/jnumed.108.058552","article-title":"Kinetic modeling of 11C-SB207145 binding to 5-HT4 receptors in the human brain in vivo.","volume":"50","author":"Marner","year":"2009","journal-title":"J Nucl Med"},{"issue":"4","key":"yoi220090r40","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1097\/00004728-199207000-00024","article-title":"Rapid automated algorithm for aligning and reslicing PET images.","volume":"16","author":"Woods","year":"1992","journal-title":"J Comput Assist Tomogr"},{"issue":"4","key":"yoi220090r41","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.neuroimage.2004.10.017","article-title":"MR-based automatic delineation of volumes of interest in human brain PET images using probability maps.","volume":"24","author":"Svarer","year":"2005","journal-title":"Neuroimage"},{"key":"yoi220090r42","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.neuroimage.2013.12.021","article-title":"Cortical surface-based analysis reduces bias and variance in kinetic modeling of brain PET data.","volume":"92","author":"Greve","year":"2014","journal-title":"Neuroimage"},{"issue":"2","key":"yoi220090r43","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.neuroimage.2012.01.021","article-title":"FreeSurfer.","volume":"62","author":"Fischl","year":"2012","journal-title":"Neuroimage"},{"issue":"4","key":"yoi220090r44","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1109\/TMI.2008.2004426","article-title":"Combined volumetric and surface registration.","volume":"28","author":"Postelnicu","year":"2009","journal-title":"IEEE Trans Med Imaging"},{"issue":"4","key":"yoi220090r45","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/(SICI)1097-0193(1999)8:4<272::AID-HBM10>3.0.CO;2-4","article-title":"High-resolution intersubject averaging and a coordinate system for the cortical surface.","volume":"8","author":"Fischl","year":"1999","journal-title":"Hum Brain Mapp"},{"issue":"9","key":"yoi220090r46","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1097\/01.WCB.0000085441.37552.CA","article-title":"Linearized reference tissue parametric imaging methods: application to [11C]DASB positron emission tomography studies of the serotonin transporter in human brain.","volume":"23","author":"Ichise","year":"2003","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1","key":"yoi220090r47","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.neuroimage.2006.05.056","article-title":"A spatially unbiased atlas template of the human cerebellum.","volume":"33","author":"Diedrichsen","year":"2006","journal-title":"Neuroimage"},{"issue":"3","key":"yoi220090r48","first-page":"513","article-title":"Noninvasive quantification of dopamine D2 receptors with iodine-123-IBF SPECT.","volume":"37","author":"Ichise","year":"1996","journal-title":"J Nucl Med"},{"key":"yoi220090r50","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.3389\/fpsyg.2019.02660","article-title":"Psychometric properties and validation of the EMOTICOM test battery in a healthy Danish population.","volume":"10","author":"Dam","year":"2019","journal-title":"Front Psychol"},{"issue":"6","key":"yoi220090r51","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1038\/jcbfm.2011.11","article-title":"Age and sex effects on 5-HT(4) receptors in the human brain: a [(11)C]SB207145 PET study.","volume":"31","author":"Madsen","year":"2011","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1","key":"yoi220090r52","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/hbm.22630","article-title":"BDNF Val66met and 5-HTTLPR polymorphisms predict a human in vivo marker for brain serotonin levels.","volume":"36","author":"Fisher","year":"2015","journal-title":"Hum Brain Mapp"},{"issue":"3","key":"yoi220090r53","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.neuroimage.2010.01.054","article-title":"Brain imaging of serotonin 4 receptors in humans with [11C]SB207145-PET.","volume":"50","author":"Marner","year":"2010","journal-title":"Neuroimage"},{"issue":"4","key":"yoi220090r54","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1007\/s00180-012-0344-y","article-title":"Linear latent variable models: the lava-package.","volume":"28","author":"Holst","year":"2013","journal-title":"Comput Stat"},{"key":"yoi220090r55","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.neuroimage.2014.01.060","article-title":"Permutation inference for the general linear model.","volume":"92","author":"Winkler","year":"2014","journal-title":"Neuroimage"},{"issue":"7","key":"yoi220090r56","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1177\/0271678X20974961","article-title":"False positive rates in positron emission tomography (PET) voxelwise analyses.","volume":"41","author":"Ganz","year":"2021","journal-title":"J Cereb Blood Flow Metab"},{"issue":"4","key":"yoi220090r57","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/mp.2013.147","article-title":"Central 5-HT4 receptor binding as biomarker of serotonergic tonus in humans: a [11C]SB207145 PET study.","volume":"19","author":"Haahr","year":"2014","journal-title":"Mol Psychiatry"},{"issue":"8","key":"yoi220090r58","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1017\/S1461145711001258","article-title":"Genetic variation in 5-hydroxytryptamine transporter expression causes adaptive changes in 5-HT4 receptor levels.","volume":"15","author":"Jennings","year":"2012","journal-title":"Int J Neuropsychopharmacol"},{"issue":"5","key":"yoi220090r59","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1111\/j.1471-4159.2009.06050.x","article-title":"The brain 5-HT4 receptor binding is down-regulated in the Flinders Sensitive Line depression model and in response to paroxetine administration.","volume":"109","author":"Licht","year":"2009","journal-title":"J Neurochem"},{"issue":"3","key":"yoi220090r60","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1111\/j.1471-4159.2009.06210.x","article-title":"Long-term treatment with fluoxetine induces desensitization of 5-HT4 receptor-dependent signalling and functionality in rat brain.","volume":"110","author":"Vidal","year":"2009","journal-title":"J Neurochem"},{"key":"yoi220090r61","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2020.110234","article-title":"Fronto-limbic neuroimaging biomarkers for diagnosis and prediction of treatment responses in major depressive disorder.","volume":"107","author":"Lai","year":"2021","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"yoi220090r62","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jad.2016.09.005","article-title":"Functional alterations of fronto-limbic circuit and default mode network systems in first-episode, drug-na\u00efve patients with major depressive disorder: a meta-analysis of resting-state fMRI data.","volume":"206","author":"Zhong","year":"2016","journal-title":"J Affect Disord"},{"issue":"4","key":"yoi220090r63","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/mp.2017.240","article-title":"CK2 regulates 5-HT4 receptor signaling and modulates depressive-like behavior.","volume":"23","author":"Castello","year":"2018","journal-title":"Mol Psychiatry"},{"issue":"18","key":"yoi220090r64","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.4103\/1673-5374.121696","article-title":"Abnormal activation of the occipital lobes during emotion picture processing in major depressive disorder patients.","volume":"8","author":"Li","year":"2013","journal-title":"Neural Regen Res"},{"issue":"1","key":"yoi220090r65","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1186\/s12888-018-1955-9","article-title":"Abnormal resting state activity of left middle occipital gyrus and its functional connectivity in female patients with major depressive disorder.","volume":"18","author":"Teng","year":"2018","journal-title":"BMC Psychiatry"},{"issue":"2","key":"yoi220090r67","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1017\/S1461145707007924","article-title":"Low GABA concentrations in occipital cortex and anterior cingulate cortex in medication-free, recovered depressed patients.","volume":"11","author":"Bhagwagar","year":"2008","journal-title":"Int J Neuropsychopharmacol"},{"key":"yoi220090r49","volume-title":"WAIS-III Administration and Scoring Manual","author":"Wechsler","year":"1997"},{"key":"yoi220090r66","first-page":"422","volume-title":"Multimodal Abnormalities of Brain Structure and Function in Major Depressive Disorder: A Meta-Analysis of Neuroimaging Studies","author":"Gray","year":"2020"}],"container-title":["JAMA Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/articlepdf\/2801424\/jamapsychiatry_khlerforsberg_2023_oi_220090_1680639150.96458.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T11:08:44Z","timestamp":1680692924000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/fullarticle\/2801424"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,1]]},"references-count":67,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamapsychiatry.2022.4539","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.06.17.21258740","asserted-by":"object"}]},"ISSN":["2168-622X"],"issn-type":[{"value":"2168-622X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4,1]]}}}